Relocalisation of KIT D816V to cell surface after Dasatinib treatment: potential clinical implications - Archive ouverte HAL Access content directly
Journal Articles Clinical Lymphoma, Myeloma & Leukemia Year : 2013

Relocalisation of KIT D816V to cell surface after Dasatinib treatment: potential clinical implications

H. Bougherara
  • Function : Author
G. Damaj
  • Function : Author
Launay J.M.
  • Function : Author
C. Auclair
  • Function : Author
M. Arock
  • Function : Author
Pascal Dubreuil
  • Function : Author
O. Hermine
Poul M.A.
  • Function : Author
No file

Dates and versions

hal-00766800 , version 1 (19-12-2012)

Identifiers

  • HAL Id : hal-00766800 , version 1

Cite

H. Bougherara, S. Georgin-Lavialle, G. Damaj, Launay J.M., L. Lhermitte, et al.. Relocalisation of KIT D816V to cell surface after Dasatinib treatment: potential clinical implications. Clinical Lymphoma, Myeloma & Leukemia, 2013, 13, pp.62-69. ⟨hal-00766800⟩

Collections

CNRS
14 View
0 Download

Share

Gmail Facebook X LinkedIn More